Vaccines & Autism


Track 11: Vaccines & Autism



Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.


    Related Conference of Vaccines & Autism

    May 25-26, 2022

    International Conference on Vaccine & Vaccine Research

    Auckland, Newzealand
    June 23-24, 2022

    International Congress on Vaccines and Virology

    Zurich, Switzerland
    June 23-24, 2022

    Global Summit on Vaccines & Emerging Diseases

    Zurich, Switzerland
    June 23-24, 2022

    35th World Congress on Vaccines and Immunization

    Bangkok, Thailand
    June 27-28, 2022

    Global Summit on Hepatitis Vaccine

    Zurich, Switzerland
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    October 05-06, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany

    Vaccines & Autism Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in